Archives

by in
Entry Author Date Location
Best Doctors Raises $45.5M for Second-Opinion Service 08/21/12 Boston
Egnyte Receives $16,000,000 Series C Financing 07/17/12 San Francisco
Kala, ImmunoGen, Boring Biotech, & More Boston Life Sciences News 07/13/12 Boston
Barkbox Receives $1,700,000 New Financing Round 07/10/12 New York
Boom or Bust? 11 Big Bets on the Future of Boston Tech 07/09/12 Boston
Who’s Still Active Among the Early-Stage Biotech VCs? 07/02/12 National
Seventh Sense, Polaris, & More Boston Life Sciences Newsmakers 06/15/12 Boston
Polaris, J&J Idea to Solve Drug R&D Crisis: Work Together Early 06/14/12 Boston
Vets First Choice Receives $4,000,000 Series C Funding 06/07/12 Boston
Ember CEO: Silicon Labs Acquisition for $72M Is “Right Thing for the Company” 05/21/12 Boston
Promedior Moves Fibrosis Pipeline to Boston, Hires Shire Vet as CEO 05/15/12 Boston
Wantful’s Customized Catalogs Aim to Bring Back Thoughtful Gift Giving 05/02/12 San Francisco
Life Sciences News: Slow-Growing Valuations & Merck/Ariad Drug 03/23/12 Boston
Wantful Receives $5,500,000 Series A Round 03/21/12 San Francisco
Kala Funnels $6.2M Into New Drugs for Eye and Lung Diseases 03/19/12 Boston
In Boston Life Sciences News: Akili, Kala, And Genocea 03/16/12 Boston
Kala Pharmaceuticals Lands $6,200,000 Seed Round 03/14/12 Boston
MicroCHIPS Shows Promise of Bone Drug Implant in First Human Trial 02/16/12 Boston
Aria Retirement Solutions Garners $4,000,000 New Round 02/04/12 San Francisco
Millennium, Vertex, Avila, & More Boston Life Sciences Newsmakers 01/27/12 Boston
Shout Outs for Avila From Polaris, Atlas, & the Twittersphere 01/26/12 Boston
Recurly Secures $6,000,000 Series A Financing Round 01/24/12 San Francisco
VC Fundraising Scorecard: General Catalyst, Excel, OpenView, & More 01/04/12 Boston
Acceleron Pharma Lands $30,000,000 New Financing 12/23/11 Boston
IBM Gets Emptoris, Nuance Buys Vlingo, & More Boston-Area Deals News 12/21/11 Boston
Vertex, Ariad, Alnylam, & More Boston-Area Life Sciences Newsmakers 12/16/11 Boston
Cerulean Pharma Adds $15M to Further Nano-Drug Platform 12/15/11 Boston
Fate Therapeutics Names Biotech Vet Bill Rastetter as Chairman, Interim CEO 12/14/11 San Diego
Lascaux, Funded by Betaworks, Launches Social Art App Mixel for iPad 11/23/11 New York
Top 10 Highlights From UnConference: Boston’s Big Data Cluster, Content Vs. Commerce & More 11/01/11 Boston
Page 2 of 19 « previous page · next page »